195 related articles for article (PubMed ID: 38614856)
1. Targeting the undruggables-the power of protein degraders.
Zhang C; Liu Y; Li G; Yang Z; Han C; Sun X; Sheng C; Ding K; Rao Y
Sci Bull (Beijing); 2024 Jun; 69(11):1776-1797. PubMed ID: 38614856
[TBL] [Abstract][Full Text] [Related]
2. Advancing targeted protein degradation for metabolic diseases therapy.
Zhou QQ; Xiao HT; Yang F; Wang YD; Li P; Zheng ZG
Pharmacol Res; 2023 Feb; 188():106627. PubMed ID: 36566001
[TBL] [Abstract][Full Text] [Related]
3. Novel approaches to targeted protein degradation technologies in drug discovery.
Xue Y; Bolinger AA; Zhou J
Expert Opin Drug Discov; 2023 Apr; 18(4):467-483. PubMed ID: 36895136
[TBL] [Abstract][Full Text] [Related]
4. Advancement of targeted protein degradation strategies as therapeutics for undruggable disease targets.
Kannan MP; Sreeraman S; Somala CS; Kushwah RB; Mani SK; Sundaram V; Thirunavukarasou A
Future Med Chem; 2023 May; 15(10):867-883. PubMed ID: 37254917
[TBL] [Abstract][Full Text] [Related]
5. Autophagy mediated targeting degradation, a promising strategy in drug development.
Zhang J; Pan X; Ji W; Zhou J
Bioorg Chem; 2024 Aug; 149():107466. PubMed ID: 38843684
[TBL] [Abstract][Full Text] [Related]
6. Emerging New Concepts of Degrader Technologies.
Ding Y; Fei Y; Lu B
Trends Pharmacol Sci; 2020 Jul; 41(7):464-474. PubMed ID: 32416934
[TBL] [Abstract][Full Text] [Related]
7. A Novel Lysosome Targeting Chimera for Targeted Protein Degradation via Split-and-Mix Strategy.
Wang J; Wang Y; Yang F; Luo Q; Hou Z; Xing Y; Lu F; Li Z; Yin F
ACS Chem Biol; 2024 May; 19(5):1161-1168. PubMed ID: 38662199
[TBL] [Abstract][Full Text] [Related]
8. Targeted protein degradation via the autophagy-lysosome system: AUTOTAC (AUTOphagy-TArgeting Chimera).
Ji CH; Lee MJ; Kim HY; Heo AJ; Park DY; Kim YK; Kim BY; Kwon YT
Autophagy; 2022 Sep; 18(9):2259-2262. PubMed ID: 35722947
[TBL] [Abstract][Full Text] [Related]
9. The AUTOTAC chemical biology platform for targeted protein degradation via the autophagy-lysosome system.
Ji CH; Kim HY; Lee MJ; Heo AJ; Park DY; Lim S; Shin S; Ganipisetti S; Yang WS; Jung CA; Kim KY; Jeong EH; Park SH; Bin Kim S; Lee SJ; Na JE; Kang JI; Chi HM; Kim HT; Kim YK; Kim BY; Kwon YT
Nat Commun; 2022 Feb; 13(1):904. PubMed ID: 35173167
[TBL] [Abstract][Full Text] [Related]
10. TACkling Cancer by Targeting Selective Protein Degradation.
Noblejas-López MDM; Tébar-García D; López-Rosa R; Alcaraz-Sanabria A; Cristóbal-Cueto P; Pinedo-Serrano A; Rivas-García L; Galán-Moya EM
Pharmaceutics; 2023 Oct; 15(10):. PubMed ID: 37896202
[TBL] [Abstract][Full Text] [Related]
11. New approaches for small molecule-induced protein degradation.
Wu S; Xiao H; Sun Q
Future Med Chem; 2021 Mar; 13(5):439-441. PubMed ID: 33438469
[No Abstract] [Full Text] [Related]
12. Tethering ATG16L1 or LC3 induces targeted autophagic degradation of protein aggregates and mitochondria.
Mei L; Chen X; Wei F; Huang X; Liu L; Yao J; Chen J; Luo X; Wang Z; Yang A
Autophagy; 2023 Nov; 19(11):2997-3013. PubMed ID: 37424101
[TBL] [Abstract][Full Text] [Related]
13. Effective degradation of EGFR
Qu X; Liu H; Song X; Sun N; Zhong H; Qiu X; Yang X; Jiang B
Eur J Med Chem; 2021 Jun; 218():113328. PubMed ID: 33773286
[TBL] [Abstract][Full Text] [Related]
14. Emerging degrader technologies engaging lysosomal pathways.
Ding Y; Xing D; Fei Y; Lu B
Chem Soc Rev; 2022 Oct; 51(21):8832-8876. PubMed ID: 36218065
[TBL] [Abstract][Full Text] [Related]
15. Targeted Protein Degradation via Lysosomes.
Paudel RR; Lu D; Roy Chowdhury S; Monroy EY; Wang J
Biochemistry; 2023 Feb; 62(3):564-579. PubMed ID: 36130224
[TBL] [Abstract][Full Text] [Related]
16. The new direction of drug development: Degradation of undruggable targets through targeting chimera technology.
Liang X; Ren H; Han F; Liang R; Zhao J; Liu H
Med Res Rev; 2024 Mar; 44(2):632-685. PubMed ID: 37983964
[TBL] [Abstract][Full Text] [Related]
17. Application of Novel Degraders Employing Autophagy for Expediting Medicinal Research.
Li X; Liu Q; Xie X; Peng C; Pang Q; Liu B; Han B
J Med Chem; 2023 Feb; 66(3):1700-1711. PubMed ID: 36716420
[TBL] [Abstract][Full Text] [Related]
18. Recent Advances of Degradation Technologies Based on PROTAC Mechanism.
Xiao M; Zhao J; Wang Q; Liu J; Ma L
Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139095
[TBL] [Abstract][Full Text] [Related]
19. Bridged Proteolysis Targeting Chimera (PROTAC) Enables Degradation of Undruggable Targets.
Xiong Y; Zhong Y; Yim H; Yang X; Park KS; Xie L; Poulikakos PI; Han X; Xiong Y; Chen X; Liu J; Jin J
J Am Chem Soc; 2022 Dec; 144(49):22622-22632. PubMed ID: 36448571
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in targeted protein degraders as potential therapeutic agents.
Yang N; Kong B; Zhu Z; Huang F; Zhang L; Lu T; Chen Y; Zhang Y; Jiang Y
Mol Divers; 2024 Feb; 28(1):309-333. PubMed ID: 36790583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
